Answer
Breastfeeding should be discontinued throughout fruquintinib (FRUZAQLA) treatment and for at least 2 weeks after the last dose.
Sources for this answer
- FRUZAQLA 1 mg hard capsulesTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked